Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Exact Sciences Corporation - Common Stock
(NQ:
EXAS
)
53.36
-0.50 (-0.93%)
Streaming Delayed Price
Updated: 1:00 PM EDT, Jul 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Exact Sciences Corporation - Common Stock
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
Are Growth Investors Finally Cutting Ties With Cathie Wood? Ark Innovation Flows Vanish As Flagship Fund Hits 5-Year Low
December 20, 2022
ARK Innovation ETF (ARCA: ARKK) hit new five-year lows on Tuesday, led by declines in the top holdings of Ark's flagship fund.
Via
Benzinga
Which Is the Better Buy: Vertex or Invitae?
December 16, 2022
Is Vertex worth its lofty valuation compared to Invitae?
Via
The Motley Fool
Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session
December 16, 2022
Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share.
Via
Benzinga
Exact Sciences's Return On Capital Employed Insights
November 22, 2022
Via
Benzinga
Nasdaq Falls Over 100 Points; Crude Oil Drops Sharply
December 16, 2022
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 100 points on Friday.
Via
Benzinga
This Nasdaq Healthcare Stock's Pain Is Its Rival's Gain
December 16, 2022
The broader market lost more ground on Friday.
Via
The Motley Fool
COSM Stock Alert: What to Know As Cosmos’ Reverse Stock Split Takes Effect
December 16, 2022
Cosmos (COSM) stock is on the move Friday as the healthcare company undergoes a name change and a reverse stock split today.
Via
InvestorPlace
Scholastic, Maxar Technologies And Some Other Big Stocks Moving Higher On Friday
December 16, 2022
U.S. stocks traded lower, with the Dow Jones dropping over 400 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
AVYA Stock Alert: Is Avaya Holdings Nearing Bankruptcy?
December 16, 2022
Avaya (AVYA) stock is falling hard on Friday following recent reports that the company is closing in on a bankruptcy filing.
Via
InvestorPlace
Why Is Exact Sciences (EXAS) Stock Up 23% Today?
December 16, 2022
Exact Sciences (EXAS) stock is on the rise Friday following news that Guardant Health's (GH) clinical trial didn't go as well as expected.
Via
InvestorPlace
Dow Drops 200 Points; Accenture Posts Upbeat Results
December 16, 2022
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 200 points on Friday.
Via
Benzinga
Guardant Health (GH) Stock Sinks on Disappointing Blood Test Results
December 16, 2022
Guardant spent more money than it took in while hoping to become a leader in cancer diagnosis, but accuracy remains a problem.
Via
InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 16, 2022
Via
Benzinga
Why Adobe Shares Are Trading Higher; Here Are 31 Stocks Moving Premarket
December 16, 2022
Gainers Minim, Inc. (NASDAQ: MINM) shares rose 66.5% to $0.2903 in pre-market trading after gaining over 10% on Thursday. Minim, last month, reported worse-than-expected results.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
December 16, 2022
We're starting off the final trading day this week with a look at the biggest pre-market stock movers to watch for Friday!
Via
InvestorPlace
Cathie Wood Adds Another $1M In Tesla After Elon Musk's Stock Sale
December 15, 2022
Cathie Wood-led ARK Investment Management continued to buy Tesla Inc (NASDAQ: TSLA) shares on Thursday with the funds purchasing over 6,000 shares of the EV maker at an estimated valuation of over $1...
Via
Benzinga
Exact Sciences Rockets As Guardant's Blood Test Pales Vs. Cologuard
December 15, 2022
Exact Sciences' Cologuard has a higher specificity than Guardant's blood test.
Via
Investor's Business Daily
After-Hours Action: What's Going On With Guardant Health, Exact Sciences Shares?
December 15, 2022
Guardant Health Inc (NASDAQ: GH) and Exact Sciences Corp (NASDAQ: EXAS) shares are moving in different directions in Thursday's after-hours session. Here's a look at what's going on.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 15, 2022
Via
Benzinga
Cathie Wood Bought TSLA Stock on the Dip. Should You?
December 15, 2022
Cathie Wood is buying up TSLA stock as Elon Musk sells more of his shares. Here's what this means for Tesla and its investors.
Via
InvestorPlace
Stock Futures Are Falling
December 15, 2022
Stock futures fell sharply on Thursday as investors worried that the Federal Reserve’s latest policy update would send the economy into a slump.
Via
Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
December 14, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 30, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 28, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
3 Healthcare Stocks That Could Set You Up For Life
November 24, 2022
All offer products that are invaluable to their respective audiences.
Via
The Motley Fool
MacroGenics To Surge 138%? Plus This Analyst Sees $50 For Exact Sciences
November 14, 2022
BMO Capital boosted the price target on MacroGenics, Inc. (NASDAQ: MGNX) from $5.7 to $16. BMO Capital analyst Etzer Darout upgraded the stock from Market Perform to Outperform. MacroGenics shares...
Via
Benzinga
As Cathie Wood's ARK ETF Surges, These 7 Stocks In The Fund Are Up Over 20% In 5 Days
November 11, 2022
Cathie Wood, the founder, CEO and CIO of ARK Investment Management, has had a tough year in the stock market as all eight of the company's exchange-traded funds (ETFs) were down substantially lower...
Via
Benzinga
Cathie Wood's ARK Innovation ETF Marks Record Surge On Thursday: Here's What She Offloaded Amid Market Rally
November 11, 2022
Cathie Wood-owned ARK Investment Management’s flagship fund, the ARK Innovation ETF (NYSE: ARKK) close
Via
Benzinga
Expert Ratings for Exact Sciences
November 08, 2022
Over the past 3 months, 4 analysts have published their opinion on Exact Sciences (NASDAQ:EXAS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Raymond James Maintains Outperform Rating for Exact Sciences: Here's What You Need To Know
November 08, 2022
Raymond James has decided to maintain its Outperform rating of Exact Sciences (NASDAQ:EXAS) and lower its price target from $70.00 to $60.00. Shares of Exact Sciences are trading up 3.28% over the last...
Via
Benzinga
< Previous
1
2
...
12
13
14
15
16
17
18
19
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.